http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8606295-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
filingDate 1985-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1986-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-8606295-A1
titleOfInvention A PROCEDURE FOR THE PREPARATION OF NEW SPIRE-3-HETEROAZOLIDINDIONAS.
abstract PROCEDURE FOR THE PREPARATION OF NEW SPIRO-E-HETEROAZOLIDINDIONAS. IT CONSISTS OF HYDROLIZING A COMPOUND OF FORMULA (II) WITH A MINERAL ACID SUCH AS TOLUENSULPHONIC, HYDROCHLORIC, HYDROBROMIC, IN TOLUENE OR 3-METHYL-2-BUTANOL, BETWEEN 80J AND 150JC, IN ORDER TO OBTAIN NEW SPIRO-HOLE-3 FORMULINDE ) AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS. BEING: X H OR ALKYL C 1 TO 4; Y Y Z, H, HAL, NITRO, TRIFLUORMETHYL AND OTHERS; O O S AND OTHERS AND N 0 O 1. THEY ARE USED AS INHIBITORS OF ALDOSA REDUCING ENZYME IN THE TREATMENT OF CHRONIC COMPLICATIONS OF DIABETES SUCH AS DIABETIC CATARACTS, RETINOPATHY AND NEUROPATHY.
priorityDate 1984-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 40.